Cancer Center Support Grant Funding Opportunity
Vanderbilt-Ingram Cancer Center (VICC) is pleased to announce the availability of funds to support translational projects that bring together a clinical and a laboratory-based investigator to generate pre-clinical data for a trial and/or to develop molecular/imaging correlatives directly related to a clinical trial. The overall purpose of this initiative is to develop novel cancer treatment approaches that require collaboration of basic and clinical investigators that ultimately lead to an investigator-initiated trial, a clinical/translational R01 or other peer-reviewed extramural support. The projects can be based on a current meritorious VICC investigator-initiated trials (IIT), including IITs receiving partial support from pharmaceutical sponsors.
Submission Deadline: Friday, May 2, 2014 by 5:00 pm.
Information and application guidelines may be obtained from Jennifer Whitsitt in the VICC Administrative Office (691 Preston Building; telephone: 936-1279 or email: firstname.lastname@example.org).